Open access · CC-BY
via OpenAlex
Proteomics efforts for hepatocellular carcinoma drug development
Dongling Jia, Zongtai Jiang, Minhui Cui, Xianting Ding
Clinical Cancer Bulletin · 2024 · ▲ 7 citations
Abstract
Abstract Hepatocellular carcinoma (HCC) is a malignant tumor associated with high global incidence and mortality rates. Proteomics, as a platform technology of cellular protein expression, modification, and interaction, has provided innovative perspectives on early diagnosis, treatment, and targeted drug development for HCC. This review summarizes recent progress in proteomics for advancing HCC biomarker discovery, drug target identification, and understanding drug action mechanisms. Proteomic technologies, including mass spectrometry for specific protein signatures identification, protein microarrays for high-throughput analysis, and bioinformatics for data interpretation, have profoundly promoted the identification of liver cancer-specific biomarkers. These advancements not only facilitate early diagnosis but also improve prognostic assessment. Proteomics is pivotal in expediting the discovery and development of new drugs, providing more effective and personalized treatment options for HCC patients. This review offers a comprehensive overview of the applications of proteomics in anti-HCC drug research, serving as a reference to further advance the development of HCC research and treatment domains.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/s44272-024-00027-7
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Jia, D., Jiang, Z., Cui, M., & Ding, X. (2024). Proteomics efforts for hepatocellular carcinoma drug development. <em>Clinical Cancer Bulletin</em>. https://doi.org/10.1007/s44272-024-00027-7
Vancouver
Jia D, Jiang Z, Cui M, Ding X. Proteomics efforts for hepatocellular carcinoma drug development. Clinical Cancer Bulletin. 2024. doi:10.1007/s44272-024-00027-7.
BibTeX
@article{dongling2024Proteo,
title = {Proteomics efforts for hepatocellular carcinoma drug development},
author = {Dongling Jia and Zongtai Jiang and Minhui Cui and Xianting Ding},
journal = {Clinical Cancer Bulletin},
year = {2024},
doi = {10.1007/s44272-024-00027-7},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Medicine 2019
Open access · OA
The biology of frailty in humans and animals: Understanding frailty and promoting translation
BENTHAM SCIENCE PUBLISHERS eBooks 2017
Citation only
Retinal Neurodegeneration in Alzheimer’s Disease
The Review of Diabetic Studies 2015
Open access · OA
Biomarkers in Diabetic Retinopathy
International Journal of Molecular Sciences 2019
Open access · CC-BY
Post-Translational Deimination of Immunological and Metabolic Protein Markers in Plasma and Extracellular Vesicles of Naked Mole-Rat (Heterocephalus glaber)
Ageing Research Reviews 2025
Open access · CC-BY
Progress in anti-ageing drug research for age-related diseases: A review
Ageing research reviews 2026
Citation only